Objective: To determine sildenafil citrate (SC) genotoxicity and cytotoxicity in the Callithrix jacchus.
Introduction
Pulmonary persistent hypertension in the neonate (PPHN) is a complex syndrome of multiple causes, with an incidence of 0.4 to 6.8 per 1000 live newborns and a mortality rate of 10 to 30%, according to the degree of severity. The survivors are at a higher risk of morbidity, including altered audition and cognitive and neurological development, as well as high risk for hospital re-admissions. The optimal management of PPHN remains controversial and includes expensive alternatives, such as highfrequency ventilation and extracorporeal membrane oxygenation. Inhaled nitric oxide is considered the 'gold standard' treatment; nevertheless, it fails in 30 to 50% of the cases and thus mortality is not modified significantly. In addition, economic and technical difficulties have limited their use in developing countries. [1] [2] [3] [4] [5] Sildenafil citrate (SC) has recently been evaluated by several investigators as an alternative to traditional therapies to dilate the pulmonary vasculature. 5 Sildenafil citrate is a selective inhibitor of phosphodiesterase type 5 (PDE-5) responsible for cyclic guanosine monophosphate (GMPc) hydrolysis in the lung. Cyclic guanosine monophosphate is an important regulator of vascular smooth muscle tone. By inhibiting PDE-5, GMPc levels can be elevated and this leads to pulmonary vasodilatation. [6] [7] [8] [9] [10] Based on PDE-5 activity in the pulmonary vasculature, some experimental studies have described that SC diminishes the pulmonary vascular resistance. [11] [12] Also case reports suggest that children and adults with pulmonary arterial hypertension have been treated successfully with oral SC. [13] [14] [15] [16] A recent proof of concept randomized controlled trial suggests benefits of oral sildenafil in newborns with PPHN, 5 and an increasing number of infants are starting to be exposed to this drug. Nevertheless, much still needs to be learned about potential adverse effects of this systemic enzymatic inhibitor, and the effects in patients who receive nitrites or have hepatic insufficiency and/or in patients who receive drugs that interact with the cytochrome system. 17 Additionally, it would be potentially serious and of grave consequences to use a drug during the neonatal period that may damage chromosomes or the cellular spindle apparatus during development. It is not currently known if oral SC at high doses can produce these undesired effects.
Micronuclei (MN) are chromosome fragments or whole chromosomes that remain out of the nucleus in mitosis. The in vivo MN assay is a useful tool to identify genotoxic drugs, compounds that break chromosomes (clastogens) or damage the spindle apparatus (aneugens). Thus, the presence of these structures is translated as DNA loss or damage and their increase is related with genotoxic exposition. 18, 19 The MN assay is widely used and it has been performed in different species and in a great variety of tissues and cells with high cellular proliferation, 18,20 -27 like peripheral blood erythrocytes. Additionally, counting the ratio of polychromatic erythrocytes (PCE) is useful to assess cytotoxicity.
The objective of this study was to determine if oral SC used at high doses during the neonatal period presents genotoxic and cytotoxic effects and systemic hemodynamic changes in the common marmoset (Callithrix jacchus). The marmoset is a recently developed non-human primate model that was chosen in the present work owing to its high spontaneous micronucleated erythrocytes (MNE) frequency and its relatively small size. 28 
Materials and methods

Experimental animals
Common marmosets were supplied by an established breeder ('Exóticos La Puerta'; Guadalajara, Jalisco, México; UMA 'La Puerta' INE-CITES-CR-IN-0024-JAL-98). All experiments were conducted with the approval of the local animal use regulatory body, which is in accordance with those approved by the National Institutes of Health (México; NOM-062-ZOO-2001).
29,30
Experimental groups and hemodynamic assessment In a randomized and double-blind trial design, 15 young common marmosets were divided randomly into three groups (five per group). 31 The experimental group received 25 mg/kg of SC (Pfizer s , Toluca, Edo. de México, México; lot 31883026B) orally 32, 33 daily for 3 consecutive days. A negative control group was given glucose solution 5% orally daily for 3 consecutive days. The third group was a positive control group. These marmosets received cytocine arabinoside (Ara-C; Sigma, St Louis, MO, USA; CAS No. 69-74-9), a well-known genotoxic drug used as positive control in genotoxicity trails. 34, 35 Cytocine arabinoside was given at 3 mg/kg intramuscularly for 2 consecutive days. All doses were adjusted to a final volume of 0.6 ml.
To determine systemic hemodynamic changes, heart rate (HR) and blood pressure (BP) were monitored every 10 min before and after each daily treatment and thereafter until the end of the treatment administration. Heart rate was monitored directly with a neonatal stethoscope and BP was determined non-invasively with an aneroid manometer and neonatal cuff.
Sample preparation and micronucleated erythrocytes analysis
Blood smears were prepared on precleaned microscope slides from each animal. A drop of peripheral blood was taken from the tip of the paw of each of the marmosets immediately before the first dose (at 0 h) and then at 24, 48, 72, 96 and 120 h later. The smears were air-dried, fixed in absolute ethanol for 10 min and stained with acridine orange. 25 Samples were scored manually using an OLYMPUS CX31 epifluorescence microscope and a Â 100 lens objective. To assess genotoxicity, the number of MNE per 10 000 total erythrocytes (TE) and the number of micronucleated polychromatic erythrocytes (MNPCE) per 2000 PCE were counted. Also, to assess cytotoxicity and as internal control of the system, the number of PCE per 1000 TE were counted. All slides were coded before microscopic analysis and were evaluated by the same reader who was masked to animal group assignment.
Statistical analysis
Statistical analysis was performed using the Statistical Program for Social Sciences (SPSS, v11.0). for Windows s medical pack (SPSS, Chicago, IL). Comparisons were made between each treatment group and their respective basal value (0 h) by means of repeated measures analysis of variance and the least significance difference test for post hoc multiple pairwise comparisons. Additionally, to evaluate the systemic hemodynamic changes pre-and posttreatments at different times in all groups, a Wilcoxon test was also performed. All results are expressed as mean±s.d.; a P-value of <0.05 was considered statistically significant.
Results
Micronucleated erythrocytes, MNPCE and PCE means, standard deviations and statistical significances from the three experimental groups are shown in Table 1 .
The experimental group and the negative control group did not show significant increases of MNE, MNPCE and PCE at any of the sampling times after treatment (24, 48, 72, 96 and 120 h). However, the positive control group had a significant increase in MNE at 96 h (P<0.002) and 120 h (P<0.008), and also MNPCE was significantly increased at 72 h (P<0.02), 96 h (P<0.007) and 120 h (P<0.003). No changes in PCE frequencies were observed.
None of the groups showed any significant effects on HR and BP values pre-and post-treatment (Tables 2 and 3) .
Discussion
In the present study, we found that oral SC administered to the common marmoset at a macro-dose more than 10 times higher than the suggested dose for children (0.5 to 2 mg/kg dose) 5 ,33 did not show genotoxic or cytotoxic effects, as evidenced by unchanged ratios of MNE, MNPCE and PCE during all sampling times.
The macro-dose of oral sildenafil chosen for this study (25 mg/ kg for 3 days) was based on toxicological protocols in rodents based on the metabolism of this species, 32 as there is no information about the use of this compound in the common marmoset. Even at this dose, no genotoxicity was identified with sildenafil. However, genotoxicity can be induced in this experimental model as confirmed by our findings in the group that received Ara-C, a known genotoxic compound. In this group, there was a significant increase of MNE by 96 h and of MNPCE by 72 h ( Table 1) .
The MNE and MNPCE are parameters related to genotoxicity and PCE is related to cytotoxicity effects. 18, 19 The positive control group allows us to evaluate the genotoxic effects of short periods of exposition (24 or 48 h) by means of MNPCE counts and to evaluate the effects of more prolonged exposition by MNE counts. Polychromatic erythrocytes counts in peripheral blood can be used to determine cytotoxicity, as these cells could be altered if the individual receives cytotoxic compounds. 36 Bone marrow toxicity can lead to decreases in PCE, and MNE production could diminish too. Because PCE do not lose their ribosomes approximately 24 h after they enter the circulation, they are stained with acridine orange, 25 colored red or orange, 37, 38, 12 making microscopic analysis easy. 18, 24 In this animal model and with these macro-doses of oral sildenafil, we did not find any effect in HR or BP. These animals were all healthy, none with pulmonary hypertension, and they remained healthy and feeding well throughout the course of the experimental design and later. However, the literature suggests the possibility of developing systemic hypotension as a result of vasodilatation induced by SC. 2, 8 Shekerdemian et al. 39 report that in piglets being treated with inhaled nitric oxide, intravenous SC (0.5 mg/kg) lowered the systemic BP and the systemic vascular resistance leading to profound arterial hypoxemia. This could be a particular characteristic of that species, as it is well known that some compounds can be species specific. 32 It is also possible that this potential adverse effect is more prevalent when sildenafil is used in cases with existing cardio-pulmonary compromise. However, a recent study in critically ill human neonates treated with oral sildenafil at 0.2 mg/kg/dose did not produce adverse hemodynamic effects. In summary, in the present study, we found no genotoxicity or cytotoxicity effects or systemic hemodynamic changes in marmosets treated with a macro-dose of oral sildenafil. These findings lend support to short-term safety of oral sildenafil, and further long-term studies need to be performed. Data are expressed as mean±standard deviation. Abbreviations: Ara-C, cytosinearabinoside; n, sample size; SC, sildenafil citrate. Pre-versus post-treatment intra-group comparisons were not significant.
